Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis.
Zhou SM, Fernandez-Gutierrez F, Kennedy J, Cooksey R, Atkinson M, Denaxas S, Siebert S, Dixon WG, O'Neill TW, Choy E, Sudlow C; UK Biobank Follow-up and Outcomes Group; Brophy S. Zhou SM, et al. Among authors: dixon wg. PLoS One. 2016 May 2;11(5):e0154515. doi: 10.1371/journal.pone.0154515. eCollection 2016. PLoS One. 2016. PMID: 27135409 Free PMC article.
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Arthritis Rheum. 2007 Sep;56(9):2905-12. doi: 10.1002/art.22809. Arthritis Rheum. 2007. PMID: 17763428 Free PMC article.
Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.
Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium; Silman AJ; British Society for Rheumatology Biologics Register. Dixon WG, et al. Arthritis Rheum. 2007 Sep;56(9):2896-904. doi: 10.1002/art.22808. Arthritis Rheum. 2007. PMID: 17763441 Free PMC article.
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.
Harrison MJ, Dixon WG, Watson KD, King Y, Groves R, Hyrich KL, Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium; BSRBR. Harrison MJ, et al. Among authors: dixon wg. Ann Rheum Dis. 2009 Feb;68(2):209-15. doi: 10.1136/ard.2007.087288. Epub 2008 Apr 2. Ann Rheum Dis. 2009. PMID: 18385277 Free PMC article.
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).
Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A; B S R B R Control Centre Consortium; Symmons DP; BSR Biologics Register. Dixon WG, et al. Ann Rheum Dis. 2010 Mar;69(3):522-8. doi: 10.1136/ard.2009.118935. Epub 2009 Oct 22. Ann Rheum Dis. 2010. PMID: 19854715 Free PMC article.
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Hyrich KL, Watson KD, Lunt M; BSRBR Control Centre Consortium; Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Ann Rheum Dis. 2010 Jun;69(6):1086-91. doi: 10.1136/ard.2009.120626. Epub 2010 May 5. Ann Rheum Dis. 2010. PMID: 20444754 Free PMC article.
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP; British Society For Rheumatology Biologics Register Control Centre Consortium; British Society for Rheumatology Biologics Register. Dixon WG, et al. Arthritis Care Res (Hoboken). 2010 Jun;62(6):755-63. doi: 10.1002/acr.20129. Arthritis Care Res (Hoboken). 2010. PMID: 20535785 Free PMC article.
No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Lunt M, Watson KD, Dixon WG; British Society for Rheumatology Biologics Register Control Centre Consortium; Symmons DP, Hyrich KL; British Society for Rheumatology Biologics Register. Lunt M, et al. Among authors: dixon wg. Arthritis Rheum. 2010 Nov;62(11):3145-53. doi: 10.1002/art.27660. Arthritis Rheum. 2010. PMID: 20662063 Free PMC article.
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.
Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP; BSRBR Control Centre Consortium; British Society for Rheumatology Biologics Register. Galloway JB, et al. Among authors: dixon wg. Rheumatology (Oxford). 2011 Jan;50(1):124-31. doi: 10.1093/rheumatology/keq242. Epub 2010 Jul 31. Rheumatology (Oxford). 2011. PMID: 20675706 Free PMC article.
206 results